Implementing a novel infectious disease diagnosis assay to a microfluidic device

Infectious diseases ranging from avian influenza to Ebola virus infection are among the most serious health emergencies in Canada and globally. Current diagnosis methods such as cell culture, ELISA and PCR suffer from inaccuracy, high-cost and lengthy procedures. Therefore, there has been a growing trend to develop new point-of-care diagnostic tools and microfluidic devices are […]

Read More
Mise au point d’une méthode rapide (ICC-qRT-PCR) pour l’analysee de l’efficacité antivirale de nouveaux désinfectants

Les infections nosocomiales sont des infections contractées dans les établissements de santé et représentent un problème de santé publique majeur. Dans les établissements de santé québécois, on évalue qu’entre 80 000 et 90 000 personnes sont atteintes d’une infection nosocomiale, ce qui correspond à 10% des admissions. Dans ce contexte, il est alors urgent de […]

Read More
Scale-up of Bioaugmentation Cultures and Development of Delivery Strategies and Monitoring Tools for Anaerobic Benzene and Alkylbenzene Bioremediation

The overall objective of this project is to scale up and demonstrate the utility of novel bioaugmentation cultures for BTEX compounds, and associated diagnostic tools to properly deploy the technology. The intern will lead the project team to develop gene-based biomarker tools applicable to the bioaugmentation cultures and apply these tools to samples submitted from […]

Read More
Développement et optimisation de procédés de production de 2 cutinases pour applications industrielles

Le but général est de favoriser la commercialisation de deux enzymes de type cutinase en développant des procédés de production/purification prometteurs et d’intérêt industriel. Les cutinases sont des enzymes intéressantes pour l’hydrolyse de divers corps gras et de certains plastiques, ainsi que pour la modification de surfaces. Pour chacune des cutinases, cinq (5) objectifs spécifiques […]

Read More
Defining cell therapies using CNS tissue sources in living Parkinson’s Disease patients

There is a critical need for new therapies for Parkinson’s Disease (PD), a devastating neurodegenerative disease. Current therapies for PD treat disease symptoms, but do not provide a cure. The ability to generate patient brain-derived cells may rapidly advance development of personalized therapies for PD and other incurable neurological disorders. This study will use brain […]

Read More
A rapid screening tool for multiple tick pathogens/Maritime tick bank

Ticks contain many different disease-causing bacteria and viruses, including the bacteria that causes Lyme disease. Multiple infections with these other pathogens in addition to Borrelia cause more severe illness. For many of these pathogens there are no or limited diagnostic tools available to detect the pathogen. This project includes production of a new product, “a […]

Read More
Site-specific Immunomodulators for COPD

Qu Biologics is a clinical-stage biopharmaceutical company developing and evaluating an innovative immunotherapeutic approach to treating disease rooted in immune pathology/dysfunction. Qu’s proprietary technology platform, site-specific immunomodulators (SSI), act to stimulate the body’s own immune system to reverse the chronic inflammation underlying many conditions including cancer and immune-mediated diseases. For lung diseases, Qu’s platform SSI, […]

Read More
Biomolecular Structure Analysis to Accelerate Develoment of New Vaccines and Monoclonal Antibodies

Manufacturing of consistently high quality products is the commitment of the pharmaceutical industry. To achieve this, new products must be thoroughly tested and the results meet government-approved product specifications. Improving existing and adopting improved analytical technologies for product testing ensure the production of safe and effective products. This is particularly critical for the manufacturing of […]

Read More
Development of a novel processing method for stabilization, extraction and bio-refining of value-added functional ingredients from marine by-products for use in feed and food products.

This research will look to extract value from marine food processing by-products through development of green chemistry technologies, to generate valuable bio-products that may be used in a health prevention role in animals and humans. This will benefit existing food processors by addressing underutilized resources, add value in the partner industry and provide tools for […]

Read More
Recherche et développement pour concevoir par fabrication additive un dispositif intra-auriculaire multifonctions: l’oreille «bionique»

La chaire de recherche industrielle en technologie intra-auriculaire (CRITIAS)-eers Global Technologies (anciennement Sonomax) développe présentement un dispositif intra-auriculaire multifonctions et personnalisé appelé oreille «bionique», qui vise à combiner différentes technologies et matériaux. Ce développement est prometteur via des prototypes de laboratoires mais des questions relatives à sa production à plus grande échelle subsistent. Les méthodes […]

Read More